Product Description :

Issue :

Saudi FDA issued Recall four batches of SABRIL 500MG F.C.TAB due to) Tiapride (cross Contamination. Sanofi-Aventis is voluntarily recalling the affected batches.

Recommendations :

For healthcare professionals, Stop dispensing the above batches immediately. Embargo/Quarantine all remaining stock. Affected batch should be returned to the supplier.

For patients,

• Consult your healthcare provider prior to discontinuing use of the affected batches, or for any health concerns.
• Contact the recalling firm or Saudi FDA if you have any questions about the recall.
• Adverse reactions or quality problems experienced with the use of this product may be reported to Saudi Vigilance either online or call center (Call 19999).